- Home
- ACLS vs BHVN Comparison
ACLS vs BHVN Comparison
Compare ACLS & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- BHVN
- Stock Information
- Founded
- ACLS 1995
- BHVN 2013
- Country
- ACLS United States
- BHVN United States
- Employees
- ACLS N/A
- BHVN N/A
- Industry
- ACLS Industrial Machinery/Components
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- ACLS Technology
- BHVN Health Care
- Exchange
- ACLS Nasdaq
- BHVN Nasdaq
- Market Cap
- ACLS 2.3B
- BHVN 1.9B
- IPO Year
- ACLS 2000
- BHVN 2017
- Fundamental
- Price
- ACLS $75.51
- BHVN $14.01
- Analyst Decision
- ACLS Buy
- BHVN Strong Buy
- Analyst Count
- ACLS 7
- BHVN 14
- Target Price
- ACLS $138.00
- BHVN $58.85
- AVG Volume (30 Days)
- ACLS 512.1K
- BHVN 1.9M
- Earning Date
- ACLS 07-30-2025
- BHVN 08-07-2025
- Dividend Yield
- ACLS N/A
- BHVN N/A
- EPS Growth
- ACLS N/A
- BHVN N/A
- EPS
- ACLS 5.46
- BHVN N/A
- Revenue
- ACLS $958,056,000.00
- BHVN N/A
- Revenue This Year
- ACLS N/A
- BHVN $3.00
- Revenue Next Year
- ACLS $7.62
- BHVN $59.97
- P/E Ratio
- ACLS $13.70
- BHVN N/A
- Revenue Growth
- ACLS N/A
- BHVN N/A
- 52 Week Low
- ACLS $40.40
- BHVN $13.75
- 52 Week High
- ACLS $158.00
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- ACLS 68.26
- BHVN 41.34
- Support Level
- ACLS $70.64
- BHVN $13.75
- Resistance Level
- ACLS $76.80
- BHVN $15.09
- Average True Range (ATR)
- ACLS 2.41
- BHVN 0.71
- MACD
- ACLS 0.18
- BHVN 0.14
- Stochastic Oscillator
- ACLS 90.42
- BHVN 20.56
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.